hoopla Digital Expands BingePass Offering with Filmocracy
/PRNewswire/ -- hoopla Digital, the only all-in-one app for public libraries, today announced the launch of a first-of-its-kind BingePass with Filmocracy that...
Stay updated with breaking news from Paul Jun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- hoopla Digital, the only all-in-one app for public libraries, today announced the launch of a first-of-its-kind BingePass with Filmocracy that...
Los Angeles, CA (PRWEB) December 07, 2021 -- Filmocracy, the world’s premiere digital screening, distribution, and experience platform, has taken a strong
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
监管“治乱象”互联网保险股应声下跌 众安、慧择、水滴保费收入却大幅增长
美赛生物是国内首家专注于肿瘤免疫微环境中巨噬细胞新靶点药物开发的新兴生物技术企业。肿瘤免疫药物是目前治疗肿瘤的最重要手段,但现有的以T细胞为主的治疗手段均存在明显的局限。而靶向巨噬细胞的药物有望弥补现有肿瘤免疫药物和治疗手段的不足。本轮融资由凯风创投领投,丹麓资本跟投,所募集的资金将主要用于现有产品管线的研发和高端人才引进。阅读全文 医疗级生物传感器企业刷新智能获数千万元融资,力合科创集团领投 投资...